Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

被引:8
|
作者
Kelepouris, Ellie [1 ]
St. Peter, Wendy [2 ,3 ]
Neumiller, Joshua J. [4 ]
Wright, Eugene E. [5 ]
机构
[1] Univ Penn, Div Renal Electrolyte & Hypertens, Philadelphia, PA 19104 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Hennepin Healthcare Res Inst, Minneapolis, MN USA
[4] Washington State Univ, Spokane, WA USA
[5] Charlotte Area Hlth Educ Ctr, Charlotte, NC USA
关键词
Chronic kidney disease; Type 2 diabetes mellitus; Multidisciplinary care; Multidisciplinary team; Care optimization; Prevention; CARDIOVASCULAR OUTCOMES; PHARMACIST INTERVENTION; MEDICATION ADHERENCE; THERAPY MANAGEMENT; NEPHROPATHY; NEPHROLOGY; MORTALITY; CKD; HOSPITALIZATION; FINERENONE;
D O I
10.1007/s13300-023-01416-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is the leading cause of chronic kidney disease (CKD), a condition associated with significant morbidity and mortality. As these patients have a high risk of developing cardiovascular disease and end-stage kidney disease, there is a need for early detection and early initiation of appropriate therapeutic interventions that slow disease progression and prevent adverse outcomes. Due to the complex nature of diabetes and CKD management, a holistic, patient-centered, collaborative care approach delivered by a coordinated multidisciplinary team (ideally including a clinical pharmacist as part of a comprehensive medication management program) is needed. In this review, we discuss the barriers to effective care, the current multidisciplinary approach used for CKD prevention and treatment, and the potential ways that the multidisciplinary management of CKD associated with type 2 diabetes mellitus can be refined to improve patient outcomes.
引用
收藏
页码:1111 / 1136
页数:26
相关论文
共 50 条
  • [21] Treatment of Type 2 Diabetes Mellitus in Advanced Chronic Kidney Disease for the Primary Care Physician
    Mallappallil, Mary
    Sasidharan, Sandeep
    Sabu, Jacob
    John, Sabu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [22] Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
    Hsu, Wei-Hao
    Hsiao, Pi-Jung
    Lin, Pi-Chen
    Chen, Szu-Chia
    Lee, Mei-Yueh
    Shin, Shyi-Jang
    ONCOTARGET, 2018, 9 (04) : 5416 - 5423
  • [23] Chronic kidney disease in patients with diabetes mellitus
    Nordheim, Espen
    Jenssen, Trond Geir
    ENDOCRINE CONNECTIONS, 2021, 10 (05) : R151 - R159
  • [24] Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
    Berezina, Tetiana A.
    Obradovic, Zeljko
    Boxhammer, Elke
    Berezin, Alexander A. A.
    Lichtenauer, Michael
    Berezin, Alexander E. E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [25] Diversity of kidney disease in patients with type 2 diabetes mellitus
    Cordonnier, DJ
    Cantin, JF
    Pinel, N
    Zaoui, P
    Castro, PP
    Vanhille, P
    Verrier-Mine, O
    Halimi, S
    PRESSE MEDICALE, 2000, 29 (35): : 1957 - 1961
  • [26] Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population
    Chung, Haechung
    Crowe, Christopher L.
    Kong, Sheldon X.
    Singh, Rakesh
    Farej, Ryan
    Elliott, Jay
    Williamson, Todd
    Willey, Vincent J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (01): : 80 - 89
  • [27] Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes Mellitus
    Low, Serena K. M.
    Sum, Chee Fang
    Yeoh, Lee Ying
    Tavintharan, Subramaniam
    Ng, Xiao Wei
    Lee, Simon B. M.
    Tang, Wern Ee
    Lim, Su Chi
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (05) : 164 - 171
  • [28] DIABETES MELLITUS TYPE 2 AND CHRONIC KIDNEY DISEASE PROGRESSION IS THERE A DIFFERENCE?
    Stefan, Gabriel
    Petrescu, Ligia
    Halip, Alexandru
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [29] Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia
    Bello, Natalie A.
    Pfeffer, Marc A.
    Skali, Hicham
    McGill, Janet B.
    Rossert, Jerome
    Olson, Kurt A.
    Weinrauch, Larry
    Cooper, Mark E.
    de Zeeuw, Dick
    Rossing, Peter
    McMurray, John J. V.
    Solomon, Scott D.
    BMJ OPEN DIABETES RESEARCH & CARE, 2014, 2 (01):
  • [30] TRENDS IN ANTIDIABETIC MEDICATION USE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE
    Gor, D.
    Touchette, D.
    VALUE IN HEALTH, 2016, 19 (03) : A210 - A210